IL39167A - X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid - Google Patents
X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acidInfo
- Publication number
- IL39167A IL39167A IL39167A IL3916772A IL39167A IL 39167 A IL39167 A IL 39167A IL 39167 A IL39167 A IL 39167A IL 3916772 A IL3916772 A IL 3916772A IL 39167 A IL39167 A IL 39167A
- Authority
- IL
- Israel
- Prior art keywords
- salt
- agent
- ray shading
- water
- base
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract 23
- 239000003795 chemical substances by application Substances 0.000 title claims 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims 13
- YBOGFJDGQDTTGW-UHFFFAOYSA-N acetamido 3-acetamido-5-hydroxy-2,4,6-triiodobenzoate Chemical compound C(C)(=O)NC=1C(=C(C(=O)ONC(C)=O)C(=C(C1I)O)I)I YBOGFJDGQDTTGW-UHFFFAOYSA-N 0.000 title claims 2
- 239000002253 acid Substances 0.000 claims abstract 8
- 239000000203 mixture Substances 0.000 claims abstract 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000007864 aqueous solution Substances 0.000 claims abstract 4
- KISFRFNQZTVXGT-UHFFFAOYSA-N 3-acetamido-5-[(2-hydroxyacetyl)amino]-2,4,6-triiodobenzoic acid Chemical compound CC(=O)NC1=C(I)C(NC(=O)CO)=C(I)C(C(O)=O)=C1I KISFRFNQZTVXGT-UHFFFAOYSA-N 0.000 claims abstract 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 18
- 238000000034 method Methods 0.000 claims 15
- 239000000243 solution Substances 0.000 claims 8
- 238000009608 myelography Methods 0.000 claims 3
- 238000007487 urography Methods 0.000 claims 3
- 238000002583 angiography Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 159000000000 sodium salts Chemical class 0.000 claims 2
- 230000001954 sterilising effect Effects 0.000 claims 2
- -1 N-methylglucamine salt Chemical class 0.000 claims 1
- 239000003708 ampul Substances 0.000 claims 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims 1
- 239000000920 calcium hydroxide Substances 0.000 claims 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2118219A DE2118219C3 (de) | 1971-04-10 | 1971-04-10 | Neues Röntgenkontrastmittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL39167A0 IL39167A0 (en) | 1972-06-28 |
| IL39167A true IL39167A (en) | 1976-01-30 |
Family
ID=5804754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL39167A IL39167A (en) | 1971-04-10 | 1972-04-10 | X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid |
Country Status (15)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH641682A5 (en) * | 1978-10-05 | 1984-03-15 | Daeniker Felix | X-ray contrast medium |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3076024A (en) * | 1954-02-19 | 1963-01-29 | Sterling Drug Inc | Acylated 3, 5-diaminopolyhalobenzoic acids |
| DE1129260B (de) * | 1961-05-12 | 1962-05-10 | Schering Ag | Roentgenkontrastmittel |
-
1971
- 1971-04-10 DE DE2118219A patent/DE2118219C3/de not_active Expired
-
1972
- 1972-03-30 AU AU40633/72A patent/AU463194B2/en not_active Expired
- 1972-03-30 IT IT22619/72A patent/IT1048929B/it active
- 1972-04-06 CH CH503472A patent/CH574740A5/xx not_active IP Right Cessation
- 1972-04-07 HU HUSCHE385*1A patent/HU163446B/hu unknown
- 1972-04-07 AT AT459173A patent/AT318801B/de not_active IP Right Cessation
- 1972-04-07 DD DD162148A patent/DD95265A5/xx unknown
- 1972-04-07 AT AT304472A patent/AT316523B/de not_active IP Right Cessation
- 1972-04-08 ES ES401603A patent/ES401603A1/es not_active Expired
- 1972-04-10 GB GB1634672A patent/GB1391843A/en not_active Expired
- 1972-04-10 BE BE781889A patent/BE781889A/xx unknown
- 1972-04-10 NL NL7204789A patent/NL7204789A/xx not_active Application Discontinuation
- 1972-04-10 IL IL39167A patent/IL39167A/en unknown
- 1972-04-10 ZA ZA722396A patent/ZA722396B/xx unknown
- 1972-04-10 CA CA139,316A patent/CA987339A/en not_active Expired
- 1972-04-10 FR FR7212450A patent/FR2132810B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU463194B2 (en) | 1975-07-02 |
| AT316523B (de) | 1974-07-10 |
| FR2132810B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-03-14 |
| HU163446B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-08-28 |
| BE781889A (fr) | 1972-10-10 |
| DE2118219A1 (de) | 1972-10-26 |
| ZA722396B (en) | 1972-12-27 |
| DE2118219B2 (de) | 1980-07-03 |
| NL7204789A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-10-12 |
| DD95265A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-01-20 |
| GB1391843A (en) | 1975-04-23 |
| AT318801B (de) | 1974-11-25 |
| IL39167A0 (en) | 1972-06-28 |
| ES401603A1 (es) | 1975-02-16 |
| CA987339A (en) | 1976-04-13 |
| IT1048929B (it) | 1980-12-20 |
| DE2118219C3 (de) | 1981-07-16 |
| AU4063372A (en) | 1973-10-04 |
| FR2132810A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-11-24 |
| CH574740A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1117013A (en) | Method for treating kidney stones | |
| US4690823A (en) | Ibuprofen-containing soft gelatin capsules and process for preparing same | |
| JP3678745B2 (ja) | 高濃度アセトアミノフェン溶液含有ゼラチンカプセル | |
| DE60126433T2 (de) | Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen | |
| JPS63145239A (ja) | Ｎｍｒ診断剤およびその製法 | |
| HRP920192A2 (hr) | Farmaceutski pripravak prikladan za djelovanje na retikuloendotelni sistem, te za tretiranje mucoviscidoza i sindroma kronične boli koji potječu od degenerativnih lokomotornih bolesti ili prate bolesti tumornog podrijetla, postupak njegovog dobivanja i upotreba | |
| NZ213185A (en) | Pharmaceutical suspensions containing sucralfate | |
| KR20150028239A (ko) | 펙틴 수용액 | |
| US4927638A (en) | Etoposide solutions | |
| TWI240630B (en) | Buffered compositions for dialysis | |
| IE42950B1 (en) | Improvements in or relating to oral x-ray contrast preparations | |
| JPH0347161A (ja) | ５―アミノサリチル酸の安定な液体形 | |
| IE74244B1 (en) | A process for preparing an antibiotic composition | |
| US3794722A (en) | Iron composition for treating anemia | |
| JP2025011312A (ja) | ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法 | |
| RU2118156C1 (ru) | Композиция - лекарственная форма противоартрозного средства глюкозамина гидрохлорида для инъекций | |
| JPH0687762A (ja) | 保存安定性硫酸グルコースアミン経口薬剤とその製造方法 | |
| IL39167A (en) | X-ray shading agents containing a water soluble salt of 3-acetamido-5-hydroxy-acetamido-2,4,6-triiodobenzoic acid | |
| CN101461801B (zh) | 一种奥沙利铂药物组合物及其制备方法 | |
| JP2563336B2 (ja) | 角膜透過促進点眼剤 | |
| EP4027977A1 (en) | Pharmaceutical composition of bimatoprost and timolol | |
| US2823163A (en) | Antivaginitis process and cation exchange resin composition | |
| DE60120630T2 (de) | Pharmazeutische Zusammensetzung enthaltend Xanthangummi | |
| US3325370A (en) | Aqueous x-ray contrast composition containing a sodium salt of an iodinated organic acid and magnesium ions | |
| CN110200905A (zh) | 一种盐酸氨溴索组合物及其注射液与应用 |